Free Trial

ANI Pharmaceuticals (ANIP) SEC Filings & 10K Form

ANI Pharmaceuticals logo
$64.96 -1.14 (-1.72%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$64.94 -0.02 (-0.04%)
As of 07/11/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ANI Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/11/2025
3:19 PM
ANI Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/16/2025
4:24 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:00 PM
ANI Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SCHEDULE 13G
06/04/2025
6:10 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
5:15 PM
ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:16 PM
ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:17 PM
ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:18 PM
ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:19 PM
ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
5:21 PM
ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
7:05 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
7:10 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
3:21 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
7:50 AM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2025
5:57 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
8:14 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:15 AM
ANI Pharmaceuticals (Filer)
Form DEFA14A
04/14/2025
3:17 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
3:38 PM
ANI Pharmaceuticals (Filer)
Form DEF 14A
04/10/2025
3:40 PM
ANI Pharmaceuticals (Filer)
Form DEFA14A
04/10/2025
3:42 PM
ANI Pharmaceuticals (Filer)
Form ARS
03/31/2025
3:35 PM
ANI Pharmaceuticals (Filer)
Form PRE 14A
03/25/2025
3:44 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:47 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
4:17 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:19 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:20 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:22 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:28 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
7:50 PM
ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
Form SCHEDULE 13D/A
03/11/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:28 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:06 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:07 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
6:05 AM
ANI Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
3:33 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:11 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
02/18/2025
7:12 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:13 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:14 PM
ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:15 PM
ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:16 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:17 PM
ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:19 PM
ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:19 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:15 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
4:59 PM
ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:35 PM
ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:20 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:08 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:38 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
6:44 PM
ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
6:00 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:01 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
5:55 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:57 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:50 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
8:13 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:23 PM
ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:44 PM
ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:29 AM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:21 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
8:51 PM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
6:26 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:53 AM
ANI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:57 AM
ANI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
4:27 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:30 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:12 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:07 PM
ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:41 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:37 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:57 PM
ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:38 PM
ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ANIP) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners